期刊文献+

蛋白结合尿毒素在心肾综合征的作用研究进展 被引量:1

Development of research in association of protein-bound uremic toxins and cardiorenal syndrome
原文传递
导出
摘要 心肾综合征(CRS)因心血管疾病与肾脏疾病共存,二者相互影响并产生恶性循环,导致临床用药矛盾,治疗困难,死亡风险高于单一心血管疾病或肾脏疾病,故引起广泛关注。关于其病理生理机制已在神经内分泌激活、血流动力学紊乱、全身炎症激活等方面有了较为系统的研究,然而,临床实践证实尽管控制了这些发病途径却仍未能阻止CRS的进展,这提示可能存在其他途径导致心、肾交互损害。随着肾移植技术的发展, Protein-bound urimic toxins(PBUTs)accumulate once renal excretory function declines,and are not cleared by dialysis.There are increasing experimental studies have shown that PBUTs are involved not only in the progression of chronic kidney disease(CKD),but also in the generation and aggravation of cardiovascular disease.It has been suggested that PBUTs are likely to be a potential missing link in cardiorenal syndrome(CRS).They are derived from dietary amino acid metabolites by colonic microbial organisms.Therefore,targeting the colon where these toxins are initially produced appears to be a potential therapeutic alternative for the progression of CKD as well as the development of CRS.The aim of this review is to evaluate the causal role of PBUTs in the pathogenesis of CRS and their elimination based on recent clinical studies.
出处 《临床急诊杂志》 CAS 2016年第9期735-738,共4页 Journal of Clinical Emergency
关键词 蛋白结合尿毒素 心肾综合征 结肠微生物代谢 protein-bound urimic toxins cardiorenal syndrome colonic microbial metabolism
  • 相关文献

参考文献1

二级参考文献16

  • 1Wheeler DC. Cardiovascular disease in patients with chronic renal failure [ J ]. Lancet, 1996,348 (9043) : 1673 - 1674.
  • 2Amann K, Gross ML, Ritz E. Pathophysiology underlying accelerated atherogenesis in renal disease: closing in on the target [J]. J Am Soc Nephrol,2004,15(6) : 1664-1666.
  • 3Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and therisks of death, cardiovascular events, and hospitalization [J ]. N Engl J Meal,2004,351 (13) : 1296-1305.
  • 4Zhao Y, Van Berkel TJ, Van Eck M. Relative roles of various efflux pathways in net cholesterol efflux from maerophage foam cells in atheroselerotic lesions [ J ]. Curr Opin Lipidol, 2010,21 (5) : 441 - 453.
  • 5Webb NR,Moore KJ. Maerophage-derived foam cells in atheroselerosis: lessons from murine models and implieations for therapy [ J ]. Curr Drug Targets, 2007,8 (12) : 1249-1263.
  • 6Ye D, Lammers B,Zhao Y, et al. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation : important targets for the treatment of atheroselerosis [J]. Curr Drug Targets,2011,12(5) :647-660.
  • 7Deguchi T,Ohtsuki S,Otagiri M,et al. Major role of organnie anion transporter 3 in the transport of Indoxyl sulfate in the kidney [J]. Kidney Int,2002,61 (5) : 1700-1768.
  • 8Oram JF, Lawn RM. ABCA1 :The gatekeeper for eliminsting excess tissue cholesterol [ J ]. J Lipid Res, 2001,42 (8) : 1173-1179.
  • 9Oram JF, Lawn RM. ATP-binding cassette cholesterol transporters and cardiovascular disease [ J ]. Cite Res, 2006,99 (10) : 1031 - 1043.
  • 10Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP- binding cassette transporter 1 is mutated in Tangier disease [J]. Nat Genet, 1999,22(4) :347-351.

共引文献1

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部